150 related articles for article (PubMed ID: 27526949)
1. Cell transfer technique for constructing cytological microarrays for immunocytochemical analysis.
Wen CH; Lin CH; Ko PL; Kuo YF; Chen YJ; Chai CY
Cytopathology; 2017 Apr; 28(2):157-163. PubMed ID: 27526949
[TBL] [Abstract][Full Text] [Related]
2. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
[TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
Afify AM; al-Khafaji BM
Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
[TBL] [Abstract][Full Text] [Related]
5. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].
Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085
[TBL] [Abstract][Full Text] [Related]
6. The application of immunocytochemistry to direct smears in the diagnosis of effusions.
Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH
Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950
[TBL] [Abstract][Full Text] [Related]
7. Expression of thyroid transcription factor-1 in malignant pleural effusions.
Khoor A; Byrd-Gloster AL; Nicosia SV
Pathol Oncol Res; 2011 Jun; 17(2):263-7. PubMed ID: 20848248
[TBL] [Abstract][Full Text] [Related]
8. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
Liu J; Farhood A
Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
[TBL] [Abstract][Full Text] [Related]
10. [Determining the primary site of metastatic adenocarcinoma in serous fluid: a cytological study].
Fang F; Yang L; Su XL; He Q; Liu DG; Lin FR; Ma ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):641-5. PubMed ID: 16536276
[TBL] [Abstract][Full Text] [Related]
11. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Kim JH; Kim YS; Choi YD; Lee JS; Park CS
Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
13. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
[TBL] [Abstract][Full Text] [Related]
15. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
[TBL] [Abstract][Full Text] [Related]
16. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
Roh MH; Schmidt L; Placido J; Farmen S; Fields KL; Courey AJ; Arenberg DA; Knoepp SM
Diagn Cytopathol; 2012 Nov; 40(11):949-55. PubMed ID: 21500373
[TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
Liu L; Cohen C; Siddiqui MT
Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
[TBL] [Abstract][Full Text] [Related]
18. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
[TBL] [Abstract][Full Text] [Related]
19. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]